- Drugmakers to pay $70 million over deals to keep cheap generics off the market https://arstechnica.com/science/2019/07/drug-makers-to-pay-70-million-over-deals-to-keep-cheap-generics-off-the-market/ 15 comments politics
- Drugmakers to pay $70 million over deals to keep cheap generics off the market https://arstechnica.com/science/2019/07/drug-makers-to-pay-70-million-over-deals-to-keep-cheap-generics-off-the-market/ 67 comments worldnews
Linking pages
Linked pages
- Drug companies are sitting on generics—43% of recently approved aren’t for sale | Ars Technica https://arstechnica.com/science/2019/02/drug-companies-are-sitting-on-generics-43-of-recently-approved-arent-for-sale/ 79 comments
- FTC Settlement of Cephalon Pay for Delay Case Ensures $1.2 Billion in Ill-Gotten Gains Relinquished; Refunds Will Go To Purchasers Affected By Anticompetitive Tactics | Federal Trade Commission https://www.ftc.gov/news-events/press-releases/2015/05/ftc-settlement-cephalon-pay-delay-case-ensures-12-billion-ill 3 comments
- Cybersecurity officials warn state and local agencies (again) to fend off ransomware | Ars Technica https://arstechnica.com/information-technology/2019/07/cybersecurity-officials-warn-state-and-local-agencies-again-to-fend-off-ransomware/ 0 comments
Related searches:
Search whole site: site:arstechnica.com
Search title: Drugmakers to pay $70 million over deals to keep cheap generics off the market | Ars Technica
See how to search.